| Q46821339 | APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals |
| Q51464229 | APOA5 variants and metabolic syndrome in Caucasians. |
| Q36745050 | An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients |
| Q40316899 | Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study |
| Q47902556 | Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity |
| Q35206176 | Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels |
| Q28273374 | Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants |
| Q35915137 | Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease |
| Q25255216 | Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy |
| Q34180234 | Atherogenic dyslipidemia: cardiovascular risk and dietary intervention |
| Q36089519 | Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation |
| Q24302828 | Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice |
| Q33727061 | Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus |
| Q24313182 | Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia |
| Q36651652 | Familial dyslipidaemias: an overview of genetics, pathophysiology and management |
| Q37116417 | Galanin preproprotein is associated with elevated plasma triglycerides |
| Q36915226 | Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease |
| Q36274976 | Give me A5 for lipoprotein hydrolysis! |
| Q82621005 | Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study |
| Q51786382 | Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. |
| Q51454108 | Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. |
| Q45041089 | Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study |
| Q35908368 | Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. |
| Q37409448 | Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk |
| Q54434575 | Molecular cloning, expression and polymorphism of the porcine apolipoprotein A5 gene in a Jinhua × Pietrain F2 reference population. |
| Q37209161 | Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis. |
| Q80827645 | Pharmacogenetics research network and knowledge base fourth scientific meeting |
| Q57365063 | Plasma apolipoprotein A5 and triglycerides in type 2 diabetes |
| Q42130406 | Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels. |
| Q42203925 | Quantitative trait loci at the 11q23.3 chromosomal region related to dyslipidemia in the population of Andhra Pradesh, India |
| Q34985872 | Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population |
| Q46908176 | The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia |
| Q45223565 | The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. |
| Q37983699 | The genetics of familial combined hyperlipidaemia |
| Q38932760 | Triglyceride Treatment in the Age of Cholesterol Reduction |
| Q36580345 | Unraveling the complex genetics of familial combined hyperlipidemia |
Search more.